See more : Golden House Ltd (GOHO.TA) Income Statement Analysis – Financial Results
Complete financial analysis of Titan Biotech Limited (TITANBIO.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Titan Biotech Limited, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Urbana Corporation (URB.TO) Income Statement Analysis – Financial Results
- Aluminum Corporation of China Limited (AOC.VI) Income Statement Analysis – Financial Results
- Hakuto Co., Ltd. (7433.T) Income Statement Analysis – Financial Results
- The Turbotville National Bank (TVNB) Income Statement Analysis – Financial Results
- Nuran Wireless Inc. (NRRWF) Income Statement Analysis – Financial Results
Titan Biotech Limited (TITANBIO.BO)
About Titan Biotech Limited
Titan Biotech Ltd. is a holding company, which engages in manufacturing and exporting of biological products used in the field of Pharmaceutical, Nutraceutical, Food & Beverages, Biotechnology & Fermentation, Cosmetic, Veterinary & Animal Feed, Agriculture Industries, Microbiology Culture Media & Plant Tissue Culture Media. The company was founded on February 18, 1992 and is headquartered in New Delhi, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.64B | 1.44B | 1.53B | 1.42B | 794.38M | 649.08M | 573.74M | 526.92M | 457.70M | 403.16M | 391.34M | 270.76M | 225.18M | 186.82M | 160.68M | 134.39M | 123.21M |
| Cost of Revenue | 1.21B | 698.73M | 748.76M | 752.84M | 476.38M | 403.73M | 384.64M | 401.80M | 339.48M | 300.92M | 302.59M | 199.55M | 167.66M | 123.38M | 125.89M | 105.93M | 86.32M |
| Gross Profit | 432.96M | 741.26M | 779.33M | 669.54M | 318.00M | 245.35M | 189.10M | 125.12M | 118.23M | 102.24M | 88.75M | 71.21M | 57.52M | 63.44M | 34.79M | 28.46M | 36.89M |
| Gross Profit Ratio | 26.39% | 51.48% | 51.00% | 47.07% | 40.03% | 37.80% | 32.96% | 23.75% | 25.83% | 25.36% | 22.68% | 26.30% | 25.54% | 33.96% | 21.65% | 21.18% | 29.94% |
| Research & Development | 1.32M | 967.01K | 1.01M | 408.21K | 460.58K | 346.15K | 914.83K | 276.11K | 237.59K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 23.95M | 18.38M | 22.48M | 15.06M | 11.00M | 11.93M | 8.58M | 7.69M | 1.13M | 1.27M | 33.96M | 26.68M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 87.63M | 76.08M | 58.66M | 42.79M | 35.33M | 27.33M | 26.78M | 22.76M | 1.80M | 1.01M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 111.58M | 94.25M | 81.14M | 57.86M | 46.33M | 39.26M | 35.36M | 30.45M | 2.94M | 2.28M | 33.96M | 26.68M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 4.16M | 19.43M | 10.23M | 1.31M | 258.72K | 126.71K | 201.44K | 2.76M | 5.48M | 3.98M | 3.82M | 2.20M | 1.32M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 117.06M | 472.07M | 394.75M | 225.80M | 200.60M | 171.41M | 128.60M | 78.81M | 86.76M | 71.69M | 65.14M | 48.66M | 39.31M | 47.24M | 21.85M | 16.80M | 25.96M |
| Cost & Expenses | 1.32B | 1.17B | 1.14B | 978.63M | 676.98M | 575.14M | 513.23M | 480.61M | 426.24M | 372.61M | 367.73M | 248.21M | 206.97M | 170.62M | 147.74M | 122.73M | 112.28M |
| Interest Income | 857.00K | 443.00K | 248.01K | 573.25K | 510.17K | 383.33K | 336.26K | -40.36K | -464.11K | -0.97 | -0.01 | 0.00 | 0.00 | 168.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 11.70M | 7.46M | 12.83M | 14.79M | 20.62M | 21.69M | 22.34M | 13.17M | 7.27M | 8.57M | 2.36M | 3.57M | 1.01M | 685.17K | 272.11K | 684.61K | 646.00K |
| Depreciation & Amortization | 33.31M | 26.00M | 23.69M | 22.20M | 18.03M | 17.15M | 9.35M | 8.29M | 7.71M | 8.38M | 8.20M | 3.58M | 3.63M | 3.28M | 2.78M | 2.57M | 2.47M |
| EBITDA | 357.99M | 314.62M | 322.10M | 464.02M | 145.43M | 95.49M | 74.24M | 56.53M | 44.19M | 42.89M | 34.56M | 26.96M | 23.25M | 19.48M | 15.71M | 14.23M | 13.39M |
| EBITDA Ratio | 21.82% | 21.85% | 27.50% | 33.14% | 17.23% | 14.83% | 12.67% | 10.52% | 9.09% | 10.31% | 8.70% | 10.46% | 10.29% | 10.43% | 9.78% | 10.59% | 10.87% |
| Operating Income | 315.90M | 274.25M | 292.44M | 438.42M | 116.82M | 72.13M | 60.43M | 45.64M | 30.90M | 33.18M | 25.84M | 24.75M | 19.53M | 16.20M | 12.93M | 11.66M | 10.93M |
| Operating Income Ratio | 19.25% | 19.05% | 19.14% | 30.82% | 14.71% | 11.11% | 10.53% | 8.66% | 6.75% | 8.23% | 6.60% | 9.14% | 8.67% | 8.67% | 8.05% | 8.67% | 8.87% |
| Total Other Income/Expenses | -608.00K | 6.91M | -2.75M | -11.37M | -13.36M | -18.50M | -19.51M | -12.82M | -4.96M | -8.68M | -3.50M | -4.94M | -1.01M | -685.00K | -272.19K | -841.83K | -646.00K |
| Income Before Tax | 315.29M | 281.16M | 381.98M | 427.06M | 104.04M | 55.44M | 41.00M | 33.49M | 26.51M | 24.50M | 22.34M | 19.80M | 18.52M | 15.51M | 12.66M | 10.97M | 10.28M |
| Income Before Tax Ratio | 19.22% | 19.53% | 25.00% | 30.02% | 13.10% | 8.54% | 7.15% | 6.36% | 5.79% | 6.08% | 5.71% | 7.31% | 8.23% | 8.30% | 7.88% | 8.16% | 8.34% |
| Income Tax Expense | 78.66M | 70.92M | 96.45M | 110.00M | 25.67M | 16.32M | 14.32M | 11.68M | 8.83M | 8.18M | 7.42M | 6.69M | 6.10M | 5.30M | 4.33M | 3.91M | 2.79M |
| Net Income | 248.53M | 248.44M | 216.84M | 303.35M | 70.66M | 35.22M | 25.43M | 21.81M | 17.68M | 16.32M | 14.92M | 13.12M | 12.42M | 10.22M | 8.32M | 7.06M | 7.49M |
| Net Income Ratio | 15.15% | 17.25% | 14.19% | 21.33% | 8.89% | 5.43% | 4.43% | 4.14% | 3.86% | 4.05% | 3.81% | 4.84% | 5.52% | 5.47% | 5.18% | 5.25% | 6.08% |
| EPS | 30.07 | 30.06 | 26.24 | 36.71 | 8.55 | 4.26 | 3.29 | 2.82 | 2.29 | 2.11 | 2.12 | 1.86 | 1.76 | 1.83 | 1.50 | 1.27 | 1.35 |
| EPS Diluted | 30.07 | 30.06 | 26.24 | 36.71 | 8.55 | 4.26 | 3.29 | 2.82 | 2.28 | 2.11 | 2.12 | 1.86 | 1.76 | 1.83 | 1.50 | 1.27 | 1.35 |
| Weighted Avg Shares Out | 8.27M | 8.26M | 8.26M | 8.26M | 8.26M | 8.26M | 7.74M | 7.74M | 7.74M | 7.74M | 7.04M | 7.04M | 7.04M | 5.58M | 5.54M | 5.54M | 5.54M |
| Weighted Avg Shares Out (Dil) | 8.27M | 8.26M | 8.26M | 8.26M | 8.26M | 8.26M | 7.74M | 7.74M | 7.74M | 7.74M | 7.04M | 7.04M | 7.04M | 5.58M | 5.54M | 5.54M | 5.54M |
No news found for: TITANBIO.BO
Source: https://incomestatements.info
Category: Stock Reports